Ngā hua rapu - Mark Fereshteh
- E whakaatu ana i te 1 - 9 hua o te 9
-
1
-
2
The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for <i>Neu</i> (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice mā Mark Fereshteh, Maddalena T. Tilli, Sung Eun Kim, Jianming Xu, Bert W. O’Malley, Anton Wellstein, Priscilla A. Furth, Anna T. Riegel
I whakaputaina 2008Artigo -
3
Targeted Disruption of β-Arrestin 2-Mediated Signaling Pathways by Aptamer Chimeras Leads to Inhibition of Leukemic Cell Growth mā Jonathan W. Kotula, Jin‐Peng Sun, Margie Li, Elizabeth D. Pratico, Mark Fereshteh, Douglas P. Ahrens, Bruce A. Sullenger, Jeffrey J. Kovacs
I whakaputaina 2014Artigo -
4
-
5
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia mā Chen Zhao, Alan Chen, Catriona Jamieson, Mark Fereshteh, Annelie Abrahamsson, Jordan Blum, Hyog Young Kwon, Juyong Brian Kim, John P. Chute, David A. Rizzieri, Michael J. Munchhof, Todd VanArsdale, Philip A. Beachy, Tannishtha Reya
I whakaputaina 2009Artigo -
6
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth mā James Kim, Jean Y. Tang, Ruoyu Gong, Juyong Brian Kim, John J. Lee, Karl V. Clemons, Curtis R. Chong, Kris S. Chang, Mark Fereshteh, Dale R. Gardner, Tannishtha Reya, Jun O. Liu, Ervin H. Epstein, David A. Stevens, Philip A. Beachy
I whakaputaina 2010Artigo -
7
Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance mā Jinqi Liu, Joshua C. Curtin, Dan You, Stephen Hillerman, Bifang Li-Wang, Rukiye Eraslan, Jenny Xie, Jesse Swanson, Ching‐Ping Ho, Simone Oppenheimer, Bethanne M. Warrack, Colleen A. McNaney, David M. Nelson, Jordan Blum, Taeg Kim, Mark Fereshteh, Michael D. Reily, Petia Shipkova, Anwar Murtaza, Miguel A. F. Sanjuán, John T. Hunt, Luisa Salter–Cid
I whakaputaina 2019Artigo -
8
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity mā Alexander Muik, Homer Adams, Friederike Gieseke, Işıl Altıntaş, Kristina B. Schoedel, Jordan M. Blum, Bianca Sänger, Saskia M. Burm, Eliana Stanganello, Dennis Verzijl, Vanessa M Spires, Fulvia Vascotto, Aras Toker, Juliane Quinkhardt, Mark Fereshteh, Mustafa Diken, David Satijn, Sebastian Kreiter, Tahamtan Ahmadi, Esther C.W. Breij, Özlem Türeci, Kate Sasser, Uğur Şahin, Maria Jure‐Kunkel
I whakaputaina 2022Artigo -
9
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors mā Alexander Muik, Elena Garralda, Işıl Altıntaş, Friederike Gieseke, Ravit Geva, Eytan Ben‐Ami, Corinne Maurice‐Dror, Emiliano Calvo, Patricia LoRusso, Guzmán Alonso, María E. Rodríguez-Ruiz, Kristina B. Schoedel, Jordan M. Blum, Bianca Sänger, Theodora W. Salcedo, Saskia M. Burm, Eliana Stanganello, Dennis Verzijl, Fulvia Vascotto, Angelica Sette, Juliane Quinkhardt, Theo S. Plantinga, Aras Toker, Edward N. van den Brink, Mark Fereshteh, Mustafa Diken, David Satijn, Sebastian Kreiter, Esther C.W. Breij, Gaurav Bajaj, Eleni Lagkadinou, Kate Sasser, Özlem Türeci, Ulf Forssmann, Tahamtan Ahmadi, Uğur Şahin, Maria Jure‐Kunkel, Ignacio Melero
I whakaputaina 2022Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Cancer research
Cell biology
Immunology
Signal transduction
Biochemistry
Cancer
Carcinogenesis
Chemistry
Cytotoxic T cell
Genetics
Immune system
In vitro
Medicine
T cell
Chronic myelogenous leukemia
Hedgehog
Hedgehog signaling pathway
Immunotherapy
Leukemia
Protein kinase B
Proto-oncogene tyrosine-protein kinase Src
Receptor
Smoothened
Stem cell
Agonist
Antibody
Antifungal
Antigen
Aptamer